Correction to: Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial - Summary - MDSpire

Correction to: Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial

  • November 6, 2025

  • 0 min

Share

Objective:

To correct inaccuracies in the original publication regarding axillary surgery and its implications in T1N0 breast cancer, specifically addressing the misinterpretation of results.

Key Findings:
  • The role of axillary surgery has evolved to a staging method with the adoption of sentinel lymph node biopsy.
  • The incidence of distant metastases among patients with axillary recurrence reflects the aggressive biology of the primary tumor.
  • Patients with axillary recurrence and distant metastases may represent a biologically aggressive subgroup with a poorer prognosis.
Interpretation:

The corrections clarify the implications of axillary surgery and the biological behavior of breast cancer in the context of distant metastases.

Limitations:
  • The erratum does not address any potential limitations of the original study design or methodology, which should be acknowledged.
Conclusion:

The amendments provide a clearer understanding of the relationship between axillary recurrence and distant metastases in breast cancer, highlighting the need for further research.

Original Source(s)

Related Content